Cargando…
The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
Nucleotide signaling molecules contribute to the regulation of cellular pathways. In the immune system, cyclic adenosine monophosphate (cAMP) is well established as a potent regulator of innate and adaptive immune cell functions. Therapeutic strategies to interrupt or enhance cAMP generation or effe...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814577/ https://www.ncbi.nlm.nih.gov/pubmed/27065076 http://dx.doi.org/10.3389/fimmu.2016.00123 |
_version_ | 1782424444274212864 |
---|---|
author | Raker, Verena Katharina Becker, Christian Steinbrink, Kerstin |
author_facet | Raker, Verena Katharina Becker, Christian Steinbrink, Kerstin |
author_sort | Raker, Verena Katharina |
collection | PubMed |
description | Nucleotide signaling molecules contribute to the regulation of cellular pathways. In the immune system, cyclic adenosine monophosphate (cAMP) is well established as a potent regulator of innate and adaptive immune cell functions. Therapeutic strategies to interrupt or enhance cAMP generation or effects have immunoregulatory potential in autoimmune and inflammatory disorders. Here, we provide an overview of the cyclic AMP axis and its role as a regulator of immune functions and discuss the clinical and translational relevance of interventions with these processes. |
format | Online Article Text |
id | pubmed-4814577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-48145772016-04-08 The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases Raker, Verena Katharina Becker, Christian Steinbrink, Kerstin Front Immunol Immunology Nucleotide signaling molecules contribute to the regulation of cellular pathways. In the immune system, cyclic adenosine monophosphate (cAMP) is well established as a potent regulator of innate and adaptive immune cell functions. Therapeutic strategies to interrupt or enhance cAMP generation or effects have immunoregulatory potential in autoimmune and inflammatory disorders. Here, we provide an overview of the cyclic AMP axis and its role as a regulator of immune functions and discuss the clinical and translational relevance of interventions with these processes. Frontiers Media S.A. 2016-03-31 /pmc/articles/PMC4814577/ /pubmed/27065076 http://dx.doi.org/10.3389/fimmu.2016.00123 Text en Copyright © 2016 Raker, Becker and Steinbrink. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Raker, Verena Katharina Becker, Christian Steinbrink, Kerstin The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases |
title | The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases |
title_full | The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases |
title_fullStr | The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases |
title_full_unstemmed | The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases |
title_short | The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases |
title_sort | camp pathway as therapeutic target in autoimmune and inflammatory diseases |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814577/ https://www.ncbi.nlm.nih.gov/pubmed/27065076 http://dx.doi.org/10.3389/fimmu.2016.00123 |
work_keys_str_mv | AT rakerverenakatharina thecamppathwayastherapeutictargetinautoimmuneandinflammatorydiseases AT beckerchristian thecamppathwayastherapeutictargetinautoimmuneandinflammatorydiseases AT steinbrinkkerstin thecamppathwayastherapeutictargetinautoimmuneandinflammatorydiseases AT rakerverenakatharina camppathwayastherapeutictargetinautoimmuneandinflammatorydiseases AT beckerchristian camppathwayastherapeutictargetinautoimmuneandinflammatorydiseases AT steinbrinkkerstin camppathwayastherapeutictargetinautoimmuneandinflammatorydiseases |